Εμφάνιση απλής εγγραφής

dc.creatorKechagia M., Michalakakou K., Griniouk K., Piante A., Karagiannidis N., Filaditaki V., Daniil Z., Papassotiriou I., Gourgoulianis K.I.en
dc.date.accessioned2023-01-31T08:34:47Z
dc.date.available2023-01-31T08:34:47Z
dc.date.issued2018
dc.identifier10.1515/cclm-2018-0331
dc.identifier.issn14346621
dc.identifier.urihttp://hdl.handle.net/11615/74728
dc.description.abstract[No abstract available]en
dc.language.isoenen
dc.sourceClinical Chemistry and Laboratory Medicineen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85048436499&doi=10.1515%2fcclm-2018-0331&partnerID=40&md5=40add914c72c48757efa8c2a646bb996
dc.subjectC reactive proteinen
dc.subjectendocanen
dc.subjectproteoglycanen
dc.subjectunclassified drugen
dc.subjectvasculotropinen
dc.subjectvon Willebrand factoren
dc.subjectbiological markeren
dc.subjectESM1 protein, humanen
dc.subjectproteoglycanen
dc.subjecttumor proteinen
dc.subjectbronchus obstructionen
dc.subjectchronic obstructive lung diseaseen
dc.subjectdifferential diagnosisen
dc.subjectdisease exacerbationen
dc.subjectdisease severityen
dc.subjectendothelial dysfunctionen
dc.subjecthospitalizationen
dc.subjecthumanen
dc.subjectimmunoturbidimetryen
dc.subjectLetteren
dc.subjectmitogenesisen
dc.subjectphenotypeen
dc.subjectpriority journalen
dc.subjectprotein blood levelen
dc.subjectprotein degradationen
dc.subjectsample sizeen
dc.subjectblooden
dc.subjectchronic obstructive lung diseaseen
dc.subjectBiomarkersen
dc.subjectHumansen
dc.subjectNeoplasm Proteinsen
dc.subjectProteoglycansen
dc.subjectPulmonary Disease, Chronic Obstructiveen
dc.subjectDe Gruyteren
dc.titleSerum endocan levels in patients with chronic obstructive pulmonary disease: A potential role in the evaluation of susceptibility to exacerbationen
dc.typeotheren


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής